Voyager Acquisition Corp
Voyager Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the healthcare or healthcare related sectors. The company was incorporated in 2023 and is based in Brooklyn, New York.
Voyager Acquisition Corp (VACH) - Net Assets
Latest net assets as of September 2025: $255.01 Million USD
Based on the latest financial reports, Voyager Acquisition Corp (VACH) has net assets worth $255.01 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($267.55 Million) and total liabilities ($12.54 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $255.01 Million |
| % of Total Assets | 95.31% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Voyager Acquisition Corp - Net Assets Trend (2023–2024)
This chart illustrates how Voyager Acquisition Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Voyager Acquisition Corp (2023–2024)
The table below shows the annual net assets of Voyager Acquisition Corp from 2023 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $247.73 Million | +4954662.48% |
| 2023-12-31 | $-5.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Voyager Acquisition Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1136728700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $259.10 Million | 104.59% |
| Total Equity | $247.73 Million | 100.00% |
Voyager Acquisition Corp Competitors by Market Cap
The table below lists competitors of Voyager Acquisition Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Huarong Chemical Co. Ltd.
SHE:301256
|
$241.08 Million |
|
AUSTRALIAN ETHICAL INV.
F:1OP
|
$241.19 Million |
|
ICRA Limited
NSE:ICRA
|
$241.21 Million |
|
Australian Ethical Investment Ltd
AU:AEF
|
$241.24 Million |
|
Isras Investment Company Ltd
PINK:IRICF
|
$240.96 Million |
|
Comptech Composites Corp
SHE:301591
|
$240.96 Million |
|
Arteche Lantegi Elkartea SA
MC:ART
|
$240.89 Million |
|
Shenzhen Infinova Ltd
SHE:002528
|
$240.84 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Voyager Acquisition Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -5,000 to 247,728,124, a change of 247,733,124.
- Net income of 4,141,371 contributed positively to equity growth.
- New share issuances of 260,690,000 increased equity.
- Other factors decreased equity by 17,098,247.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $4.14 Million | +1.67% |
| Share Issuances | $260.69 Million | +105.23% |
| Other Changes | $-17.10 Million | -6.9% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Voyager Acquisition Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.46x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-12-31 | $0.00 | $11.67 | x |
| 2024-12-31 | $25.24 | $11.67 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Voyager Acquisition Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.67%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.05x
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2024 | 1.67% | 0.00% | 0.00x | 1.05x | $-20.63 Million |
Industry Comparison
This section compares Voyager Acquisition Corp's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Voyager Acquisition Corp (VACH) | $255.01 Million | 1.67% | 0.05x | $241.06 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |